164 related articles for article (PubMed ID: 34984178)
1. An experimental model of the epithelial to mesenchymal transition and pro-fibrogenesis in urothelial cells related to bladder pain syndrome/interstitial cystitis.
Jin XW; Wang QZ; Zhao Y; Liu BK; Zhang X; Wang XJ; Lu GL; Pan JW; Shao Y
Transl Androl Urol; 2021 Nov; 10(11):4120-4131. PubMed ID: 34984178
[TBL] [Abstract][Full Text] [Related]
2. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.
Jiang YH; Peng CH; Liu HT; Kuo HC
PLoS One; 2013; 8(10):e76779. PubMed ID: 24146927
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive transcriptome profiling of urothelial cells following TNFα stimulation in an
Kuret T; Peskar D; Kreft ME; Erman A; Veranič P
Front Immunol; 2022; 13():960667. PubMed ID: 36045687
[TBL] [Abstract][Full Text] [Related]
4. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
5. Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1.
Wang J; Chen Y; Gu D; Zhang G; Chen J; Zhao J; Wu P
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F961-F972. PubMed ID: 28331066
[TBL] [Abstract][Full Text] [Related]
6. Microrna-139-5p inhibits epithelial-mesenchymal transition and fibrosis in post-menopausal women with interstitial cystitis by targeting LPAR4 via the PI3K/Akt signaling pathway.
Jiang C; Tong Z; Fang WL; Fu QB; Gu YJ; Lv TT; Liu DM; Xue W; Lv JW
J Cell Biochem; 2018 Aug; 119(8):6429-6441. PubMed ID: 29240250
[TBL] [Abstract][Full Text] [Related]
7. Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal.
Fang W; Song Q; Lv T; Lv J; Cai Z; Wang Z; Song X; Ji X; Huang J
Int Urol Nephrol; 2023 Dec; 55(12):3065-3075. PubMed ID: 37594700
[TBL] [Abstract][Full Text] [Related]
8. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
Lee CL; Jiang YH; Kuo HC
BJU Int; 2013 Dec; 112(8):1156-62. PubMed ID: 23937072
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous stimulation with tumor necrosis factor-α and transforming growth factor-β1 induces epithelial-mesenchymal transition in colon cancer cells via the NF-κB pathway.
Li Y; Zhu G; Zhai H; Jia J; Yang W; Li X; Liu L
Oncol Lett; 2018 May; 15(5):6873-6880. PubMed ID: 29725419
[TBL] [Abstract][Full Text] [Related]
12. Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.
Cui X; Jing X; Lutgendorf SK; Bradley CS; Schrepf A; Erickson BA; Magnotta VA; Ness TJ; Kreder KJ; O'Donnell MA; Luo Y
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F90-F98. PubMed ID: 31091120
[TBL] [Abstract][Full Text] [Related]
13. Cdk1/p53/p21 feedback loop mechanisms in the pathogenesis of interstitial cystitis/bladder pain syndrome.
Wang K; Shi J; Chen Z; Xue D; He X
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; ():167305. PubMed ID: 38880159
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha.
Câmara J; Jarai G
Fibrogenesis Tissue Repair; 2010 Jan; 3(1):2. PubMed ID: 20051102
[TBL] [Abstract][Full Text] [Related]
15. Identification of key pathways and mRNAs in interstitial cystitis/bladder pain syndrome treatment with quercetin through bioinformatics analysis of mRNA-sequence data.
Wang G; Li P; Su SW; Xu R; Huang ZY; Yang TX; Li JM
Aging (Albany NY); 2024 Mar; 16(7):5949-5966. PubMed ID: 38526326
[TBL] [Abstract][Full Text] [Related]
16. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
Jiang YH; Jhang JF; Kuo HC
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252
[TBL] [Abstract][Full Text] [Related]
17. Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome.
Shie JH; Liu HT; Kuo HC
Urology; 2012 Feb; 79(2):484.e7-13. PubMed ID: 22310775
[TBL] [Abstract][Full Text] [Related]
18. Bioenergetic profiles of peripheral mononuclear cells and systemic inflammation in women with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
Kumar P; Oster RA; Assimos DG; Ness TJ; Mitchell T
PLoS One; 2024; 19(2):e0298981. PubMed ID: 38359038
[TBL] [Abstract][Full Text] [Related]
19. SMAD inhibition attenuates epithelial to mesenchymal transition by primary keratinocytes in vitro.
O'Kane D; Jackson MV; Kissenpfennig A; Spence S; Damkat-Thomas L; Tolland JP; Smyth AE; Denton CP; Stuart Elborn J; McAuley DF; O'Kane CM
Exp Dermatol; 2014 Jul; 23(7):497-503. PubMed ID: 24848428
[TBL] [Abstract][Full Text] [Related]
20. Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease.
Jhang JF; Kuo HC
Int Neurourol J; 2016 Nov; 20(Suppl 2):S95-104. PubMed ID: 27915472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
